鞣花酸联合替莫唑胺调控胶质母细胞瘤模型钙黏蛋白转换与血管生成
研究在大鼠C6胶质瘤细胞中评估鞣花酸(EA)联合替莫唑胺(TEM)对钙黏蛋白转换和血管生成的影响。100 μM EA与100 μM TEM处理24、48、72小时后,联合处理在所有孵育时间均显著降低细胞活力(P < 0.001)。EA上调E-钙黏蛋白并下调N-钙黏蛋白,联合TEM在24小时增强该效应,且仅在72小时下调VEGF。
要点
- EA联合TEM在所有时间点显著降低C6胶质瘤细胞活力(P < 0.001)。
- EA上调E-钙黏蛋白、下调N-钙黏蛋白,联合TEM在24小时增强该效应。
- 联合处理仅在72小时下调VEGF基因表达与免疫反应性。
核心结论
- EA联合TEM可能通过抑制钙黏蛋白转换和血管生成发挥治疗作用。
研究设计与样本
- 体外研究:大鼠C6胶质瘤细胞,100 μM EA与100 μM TEM处理24、48、72小时。
- 用BrdU免疫组化检测细胞增殖,用实时PCR和免疫组化检测E-钙黏蛋白、N-钙黏蛋白和VEGF。
主要发现
- EA联合TEM在所有孵育时间显著降低C6胶质瘤细胞活力(P < 0.001)。
- EA以时间非依赖方式上调E-钙黏蛋白基因(P < 0.05)和蛋白(P < 0.001)表达。
- 联合TEM在24小时增强E-钙黏蛋白上调(P < 0.01)。
- EA以时间非依赖方式降低N-钙黏蛋白表达(P < 0.05)和免疫反应性(P < 0.001),联合TEM在24小时增强该效应(P < 0.001)。
- 联合处理仅在72小时下调VEGF基因表达(P < 0.001)和免疫反应性(P < 0.001)。
临床怎么用
- 提示EA联合TEM可能通过调控钙黏蛋白转换与血管生成影响胶质瘤生物学行为,尚待进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to evaluate the combined effect of ellagic acid (EA) and temozolomide (TEM) on the cadherin switch and angiogenesis in the C6 glioma cell line. METHODS: A total of 100 μM EA and 100 μM TEM were applied to rat C6 glioma cells for 24, 48, and 72 hours. Cell proliferation was detected by 5-bromo-2'-deoxyuridine immunohistochemistry. The messenger RNA and protein levels of E-cadherin, N-cadherin, and vascular endothelial growth factor (VEGF) were determined by real-time polymerase chain reaction and their immunohistochemistry, respectively, subsequent to EA treatment combined with TEM. RESULTS: EA in combination with TEM conspicuously reduced the viability of C6 glioma cells at all incubation times (P < 0.001). EA upregulated the expression of E-cadherin at the gene and protein levels in a time-independent manner (P < 0.05 and P < 0.001, respectively). By the presence of TEM, the increase was exaggerated at 24-hour incubation (P < 0.01). Conversely, EA reduced N-cadherin expression and immunoreactivity in a time-independent manner (P < 0.05 and P < 0.001, respectively), and combination with TEM enhanced this effect at the 24th hour (P < 0.001). Combination also downregulated the gene expression (P < 0.001) and immunoreactivity of VEGF only at 72 hours (P < 0.001). CONCLUSIONS: A successful therapeutic efficacy of EA combined with TEM is suggested probably by inhibiting the cadherin switch and angiogenesis.
引用
- Çetin A, Biltekin B. Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model. World Neurosurg. 2019. PMID: 31505280. doi:10.1016/j.wneu.2019.08.228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。